Abstract
Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for diagnosis and post-therapeutic assessment. However, recent advances in these modalities, in league with the emerging fields of radiomics and theranostics, may prove helpful in improving diagnostic accuracy and treating the disease.
| Original language | English (US) |
|---|---|
| Article number | 4162 |
| Journal | Cancers |
| Volume | 15 |
| Issue number | 16 |
| DOIs | |
| State | Published - Aug 2023 |
Keywords
- CT
- GBM
- glioblastoma
- glioma
- high-grade glioma
- MRI
- PET
- radiomics
- theranostics
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Advances in the Radiological Evaluation of and Theranostics for Glioblastoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS